2002, Number 1
<< Back Next >>
Vet Mex 2002; 33 (1)
Immunogenic evaluation of Giardia the reds-vax vaccine´s activitys using an experimental model of giardiasis in gerbils (Meriones unguiculatus)
Jiménez-Cardoso E, Eligio-García L, Cortés-Campos A
Language: English/Spanish
References: 25
Page: 49-54
PDF size: 113.79 Kb.
ABSTRACT
Evaluation of the prophylactic activity of a vaccine Giardia-vax against experimental infection on Meriones unguiculatus (gerbils) challenges with Giardia intestinalis trophozoites, was tested. Forty five animals with a body weight of 16.0 ± 0.5 g were used and divided in three Groups: a) the control, without inoculation; b) the positive control, infected via gastric with 1 × 107 trophozoites from Portland-I type Giardia intestinalis; and c) the vaccinated group, which received two doses of 1mL of Giardia vaccine with an interval of a week between both doses. Thereafter, animals were infected with 1× 107 Giardia trophozoites. A coproparasitoscopic (CPS) analysis was carried out every third day for 15 days after the infection. A serum antibody test (ELISA) against Giardia was performed before- and after the vaccination or the infection. Group a) did not eliminate Giardia when CPS analysis was performed; Group b) showed elimination of Giardia all the time; and in Group c), 5/15 animals had negative CPS from the third day on after the infection until the end of the study, and the other 10/15 animals showed positive CPS until the seventh day; and after this, all CPS were negative. Groups b) and c) had serum antibodies that statistically had a P ‹ 0.05 before- and after infection. Levels of antibodies were higher in Group c) and in five of them. No colonization was observed to trophozoites. These results suggest that the vaccine was able to stimulate antibodies to Giardia protecting animals against future infections.
REFERENCES
Adam RD. The biology of Giardia spp. Microbiol Rev 1991;55:706-32.
2. WHO (1996). The world health report. Washington (DC): World Health Organization, 1996.
3. Hermida RC, Ayala DE, Arroyave RJ. Circannual incidence of Giardia lamblia in Mexico. Chronobiol Int 1990;7:329-40.
4. Hill DR. Giardiasis. Issues in diagnosis and management. Infect Dis Clin North Am 1993;7:503-525.
5. Lewis DJ, Freedman AR. Giardia lamblia as an intestinal pathogen. Dig Dis 1992;10:102-111.
6. Farthing MJ. Giardiasis. Gastroenterol Clin North Am 1996;25:493-515.
7. Erlandsen SL, Chase DG. Morphological alterations in the microvillous border of villous epithelial cells produced by intestinal microorganisms. Am J Clin Nutr 1974;27:1277-1286.
8. Savidge TC, Shmakov AN, Walker-Smith JA, Phillips AD. Epithelial cell proliferation in childhood enteropathies. Guts 1996;39:185-193.
9. Hill SL, Cheney JM, Taton-Allen GF, Reif JS, Bruns C, Lappin MR. Prevalence of enteric zoonotic organisms in cats. J Am Vet Med Assoc 2000;216:687-692.
10. Barr SC, Bowman DD. Giardiasis in dogs and cats. Comp Cont Educ Pract Vet 1994;16:603-614.
11. Marshall MM, Naumovits D, Ortega Y, Sterling CR. Waterbone protozoan pathogens. Clin Microbiol Rev 1997;10:67-85.
12. Vinayak, VK, Kum Khanna R, Khuller M. Systemic-oral immunization with 56 kDa molecule of Giardia lamblia affords protection in experimental mice. Vaccine 1992;10:21-27.
13. Olson ME, Morck DW, Ceri H. Preliminary data on the efficacy of a Giardia vaccine in puppies. Can Vet J 1997;38:777-779.
14. Olson ME, Ceri H, Morck DW. Giardia vaccination. Parasitol Today 2000;16:213-217.
15. Faust EC, D´Santoni JS. A clinical study of laboratory techniques for the diagnosis of protozoan cysts and helminth eggs in faeces. Am J Trop Med 1938;18:169-183.
16. Yanke, SJ. Ceri H, McAllister TA, Morck DW, Olson ME. Serum immune response to Giardia in experimentally infected lambs. Vet Parasitol 1998;75:9-19.
17. Keister DB. Axenic culture of Giardia lamblia in TYI-S-33 medium supplemented with bile. Trans R Soc Trop Med Hyg 1983;77:487-488.
18. INSO corporation. SPSS® base 10.0. Applications guide. Chicago (Il): SPSS Inc., 1999.
19. Chaudhuri PP, Das D, Sarkar S, Munoz ML, Das P. Biochemical and immunological characterization of soluble antigens of Giardia lamblia. Parasitol Res 1997;83:604-610.
20. Olson ME. Giardia vaccine. United States Patent 554;9899. Calgary, Canada: United States Patent Office,1996.
21. Buret A. Surface antigen variability and variation in Giardia lamblia. Parasitol Today 1992; 8:229-234.
22. Faubert GM. Evidence that giardiasis is a zoonosis. Parasitol Today 1998;4:66-71.
Di Prisco MC, Hagel L, Lynch NR, Jimenez JC, Rojas R, Gil M, Mata E. Association between giardiasis and allergy. Ann Allergy Asthma Immunol 1998;81:261-265.
24. Letts M, Davidson D, Lalonde F. Synovitis secondary to giardiasis in children. Am J Orthop 1998;27:451-454.
25. Shaw RA, Stevens MB. The reactive arthritis of giardiasis, a case report. J Am Med Assoc 1987;258:2734-2735.
Full text